New Key Statistics Module, Z-Score and F-Score
NYSE:TEVA Key Ratios
Market Cap $ M | 14,676.76 |
Enterprise Value $ M | 31,405.60 |
P/E(ttm) | -- |
PE Ratio without NRI | 5.08 |
Forward PE Ratio | 5.62 |
Price/Book | 1.92 |
Price/Sales | 0.91 |
Price/Free Cash Flow | 16.98 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 15,846.00 |
EPS (TTM) $ | -0.47 |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 77.54 |
EV-to-EBITDA | 20.16 |
PEG | -- |
Shares Outstanding M | 1,132.64 |
Net Margin (%) | -3.53 |
Operating Margin % | 20.14 |
Pre-tax Margin (%) | -3.94 |
Quick Ratio | 0.69 |
Current Ratio | 1.02 |
ROA % (ttm) | -1.29 |
ROE % (ttm) | -7.52 |
ROIC % (ttm) | 8.33 |
Dividend Yield % | -- |
Altman Z-Score | 0.21 |
TEVA Number of Guru Trades
TEVA Volume of Guru Trades
Gurus Latest Trades with NYSE:TEVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TEVA is held by these investors
Total 2
Teva Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about NYSE:TEVA
Total 0- 1